Thrombin and vascular smooth muscle cell proliferation: Implications for atherosclerosis and restenosis

Seminars in Thrombosis and Hemostasis

Volumn 22, Issue 2, 1996, Pages 139-144

  McNamara, Coleen A ^a,b   Sarembock, Ian J ^a   Bachhuber, Brian G ^a   Stouffer, George A ^a   Ragosta, Michael ^a   Barry, William ^a   Gimple, Lawrence W ^a   Powers, Eric R ^a   Owens, Gary K ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Atherosclerosis; Proliferation; Smooth muscle cells; Thrombin; Vascular injury

Indexed keywords

THROMBIN;

ATHEROSCLEROSIS; CELL PROLIFERATION; CONFERENCE PAPER; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTENOSIS; THROMBOGENESIS; VASCULAR SMOOTH MUSCLE;

EID: 0029894138     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-999001     Document Type: Conference Paper

References (55)

1. von Rokitansky C: A Manual of Pathologic Anatomy. The Sydenham Society, London, 1852.
2. Ross R: The pathogenesis of atherosclerosis: An update. N Engl J Med 314:488-500, 1986.
3. Davies MJ, N Woolf. Atheroma: Atherosclerosis in Ischaemic Heart Disease. Vol. I: The Mechanisms. Science Press, London, 1990.
4. Schwartz CJ, AJ Valente, JL Delley, EA Sprague, EH Edwards: Thrombosis and the development of atherosclerosis: Rokitansky revisited. Semin Thromb Hemostas 14:189-193, 1988.
5. Chesebro JH, MW Webster, P Zoldhelyi, PC Roche, L Badimon, JJ Badimon: Antithrombotic therapy and progression of coronary artery disease: Antiplatelet versus antithrombins. Circulation 86(Suppl III):III-100-III-111, 1992.
6. Fenton II JW, TA Olson, MP Zabinski, DG Wilner. Anion-binding exosite of human α-thrombin and fibrin(ogen) recognition. Biochemistry 27:7106-7112, 1988.
7. Malik AB, JW Fenton II: Thrombin-mediated increase in vascular endothelial permeability. Semin Thromb Hemostas 18:193-199, 1992.
8. Sugama Y, AB Malik: Thrombin receptor 14-amino acid peptide mediates endothelial hyperadhesivity and neutrophil adhesion by P-selectin-dependent mechanism. Circ Res 71:1015-1019, 1992.
9. Hollenberg MD, SG Yang, AA Laniyonu, GJ Moore, M Saifeddine: Action of thrombin receptor polypeptide in gastric smooth muscle: Identification of a core pentapeptide retaining full thrombin-mimetic intrinsic activity. Mol Pharmacol 42:186-191, 1992.
10. Vu TK, DT Hung, VI Wheaton, SR Coughlin: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068, 1991.
11. Vouret-Craviari V, E Van Obberghen-Schilling, UB Rasmussen, A Pavirani, JP Lecocp, J Pouyssegur: Synthetic alpha thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis. Mol Cell Biol 3:95-102, 1992.
12. Bar-Shavit R, AJ Kahn, KG Mann, GD Wilner: Identification of a thrombin sequence with growth factor activity on macrophages. Proc Natl Acad Sci USA 83:976-980, 1986.
13. McNamara CA, IJ Sarembock, LW Gimple, JW Fenton II, SR Coughlin, GK Owens: Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 91:94-98, 1993.
14. Lui MW, GS Roubin, SB King: Restenosis after coronary angioplasty: Potential biologic determinants and role of intimai hyperplasia. Circulation 79:1374-1387, 1989.
15. Harker LA: Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. Am J Cardiol 60:20B-28B, 1987.
16. Chesebro JH, JYT Lam, L Badimon, V Fuster: Restenosis after arterial angioplasty: A hemorrheologic response to injury. Am J Cardiol 60:10B-16B, 1987.
17. Walz DA, GF Anderson, RE Ciaglowski, M Aiken, JW Fenton II: Thrombin-elicited contractile response of aortic smooth muscle. Proc Soc Exp Biol Med 180:518-526, 1985.
18. Bar-Shavit R, A Eldor, L Vlodavsky: Binding of thrombin to subendothelial extracellular matrix: Protection and expression of functional properties. J Clin Invest 84:1096-1104, 1989.
19. Wilner GD, MP Danitz, MS Mudd, K-H Hsieh, JW Fenton II: Selective immobilization of alpha-thrombin by surface-bound fibrin. J Lab Clin Med 97:403-411, 1981.
20. Bar-Shavit R, M Benezra, A Eldor, E HyAm, JW Fenton II, GD Wilner, I Vlodavsky: Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: Non-enzymatic mode of action. Cell Regulation 1:453-463, 1990.
21. Sarembock IJ, SD Gertz, LW Gimple, RM Owen, ER Powers, WC Roberts: Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation 84:232-243, 1991.
22. 2+ mobilization. FEBS Lett 288:123-128, 1991.
23. Nobuyoshi M, T Kimurs, H Ohishi, H Horiuchi, H Nosaka, N Hamasaki, H Yokoi, K Kim: Restenosis after percutaneous transluminal coronary angioplasty: Pathologic observations in 20 patients. J Am Coll Cardiol 17:433-439, 1991.
24. Steele PM, JH Chesebro, AW Stanson, DR Holmes, MK Dewanjee, L Badimon, V Fuster: Balloon angioplasty: Natural history of the pathophysiological response to injury in a pig model. Circ Res 57:105-112, 1985.
25. Herbert JM, I Lamarche, F Dol: Induction of vascular smooth muscle cell growth by selective activation of the thrombin receptor: Effect of heparin. FEBS Lett 301:155-158, 1992.
26. Ishii K, L Hein, B Kobika, SR Coughlin: Kinetics of thrombin receptor cleavage on intact cells: Relation to signaling. J Biol Chem 268:9780-9786, 1993.
27. Hoxie JA, M Ahuja, E Belmonte, S Pizarro, R Parton, LF Brass: Internalization and recycling of activated thrombin receptors. J Biol Chem 268:13756-13763, 1993.
28. Bachhuber BG, IJ Sarembock, CA McNamara, LW Gimple, GK Owens: Thrombin-induced proliferation of cultured vascular smooth muscle cells requires prolonged exposure to thrombin. Am J Physiol 268-.C1141-C1147, 1995.
29. Stouffer GA, IJ Sarembock, CA McNamara, LW Gimple, GK Owens: Thrombin-induced mitogenesis of vascular SMC is partially mediated by autocrine production of PDGF-AA. Am J Physiol 265:C806-C811, 1993.
30. Raines EW, SK Dower, R Ross: Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 243:393-396, 1989.
31. Stouffer GA, GK Owens: Angiotensin II induced mitogenesis of SHR derived cultured smooth muscle cells is dependent on transforming growth factor-β. Circ Res 70:820-828, 1992.
32. Battegay EJ, EW Raines, RA Seifert, DF Bowen-Pope, R Ross: TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63:515-524, 1990.
33. Majack RA, MW Jajesky, LV Goodman: Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta. J Cell Biol 111:239-247, 1990.
34. Weiss RH, M Maduri: The mitogenic effect of thrombin in vascular smooth muscle cells is largely due to basic fibroblast growth factor. J Biol Chem 268:5724-5727, 1993.
35. Vouret-Craviari V, E Van Obberghen-Schilling, UB Rasmussen, A Pavirani, JP Lecocp, J Pouyssegur: Synthetic alpha thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis. Mol Cell Biol 3:95-102, 1992.
36. Carney DH, J Stiernberg, JW Fenton II: Initiation of proliferative events by human α-thrombin requires both receptor binding and enzymatic activity. J Cell Biochem 26:181-195, 1984.
37. Van Obberghen-Schilling E, J Pouyssegur: α-Thrombin receptors and growth signaling. Semin Thromb Hemostas 19:378-385, 1993.
38. Nelken NA, SJ Soifer, J O'Keefe, TK Vu, IF Charo, SR Coughlin: Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Invest 90:1614-1621, 1992.
39. Wilcox J, J Ollerenshaw, RR Subramanian, LA Harker, SR Hanson, AB Kelly, MS Runge: Localization of thrombin receptor expression in proliferating smooth muscle cells in vivo. (Abst.) Circulation 86:1-150, 1992.
40. Ragosta M, WL Barry, KW McCoy, LW Gimple, GA Stouffer, CA McNamara. ER Powers, GK Owens, IJ Sarembock: Early kinetics of cellular proliferation after balloon angioplasty in atherosclerotic rabbits. (Abst.) Clin Res 42:180A, 1994.
41. Clowes AW, MM Clowes: Kinetics of cellular proliferation after arterial injury: Inhibition of smooth muscle growth by heparin. Lab Invest 52:611-616, 1985.
42. Hanke H, T Strohschneider, M Oberhoff, E Betz, KR Karsch: Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res 67:651-659, 1990.
43. Faxon DP, TA Sanborn, VJ Weber, C Haudenschild, SB Gottsman, WA McGovern, TJ Ryan: Restenosis following transluminal angioplasty in experimental atherosclerosis. Arteriosclerosis 4:189-195, 1984.
44. Walters TK, DA Gorog, RFM Wood: Thrombin generation following arterial injury is a critical initiating event in the pathogenesis of the proliferative stages of the atherosclerotic process. J Vasc Res 31:173-177, 1994.
45. Nobuyoshi M, M Tanaka, M Fujii, A Asanuma, M Takimoto: Thrombus formation on the aorta injured by angioplasty and its prevention with dilazep in atherosclerotic rabbits. Thromb Res 54:561-572, 1989.
46. Harlan JM, PJ Thompson, RR Ross, DF Bowen-Pope: Alpha-thrombin induces release of platelet-derived growth factor-like molecule(s) by cultured human endothelial cells. J Cell Biol 103:1129-1133, 1986.
47. Vlodavsky I, J Folkman, R Sullivan, R Fridman, R Ishai-Michaeli, J Sasse, M Vlagshrun: Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into subentlothelial extracellular matrix. Proc Natl Acad Sci USA 84:2292-2296, 1987.
48. Ross R, J Glomset, B Karlya, L Harker: A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 71:107-1210, 1974.
49. 1 during repair of arterial injury. J Clin Invest 88:904-910, 1991.
50. Clinton SK, CA Dinarello, JG Cannon, AR Shaw, P Libby: Induction in vitro of interleukin-1 (IL-1) gene expression in rabbit aortic tissue. (Abst.) Circulation 78(Suppl II):II-65, 1988.
51. Douglas SA, C Louden, LM Vickery-Clark, BL Storer, T Hart, GZ Feuerstein, JD Elliott, EH Ohlstein: A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. Circ Res 75:190-197, 1994.
52. Sigal SL, J Gellman, IJ Sarembock, PJ La Veau, QS Chen, HS Cabin, MD Ezekowitz: Effects of serotonin-receptor blockade on angioplasty-induced vasospasm in an atherosclerotic rabbit model. Arterioscler Thromb 11:770-783, 1991.
53. Mugge A, DD Heistad, P Densen, DJ Piegors, ML Armstrong, RC Padgett, JA Lopez: Activation of leukocytes with complement C5a is associated with prostanoid-dependent constriction of large arteries in atherosclerotic monkeys in vivo. Atherosclerosis 95: 211-222, 1992.
54. Seino Y, U Ikeda, M Ikeda, K Yamamoto, Y Misawa, T Hasegawa, S Kano, K Shimada: Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 6:87-91, 1994.
55. Gravanis MB, GS Roubin: Histopathologic phenomena at the site of percutaneous transluminal coronary angioplasty: The problem of restenosis. Hum Pathol 20:477-485, 1989.